Development of an injectable salicylic acid–choline eutectic hydrogel for enhanced treatment of periodontitis

A DES-CS/GP hydrogel was developed for periodontitis, showing injectability, antimicrobial and anti-inflammatory activities, good gingival permeability and biocompatibility. It reduced bone loss, bacterial loads, and cytokine expression in rat.